Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

1,921 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,921 results

Post-approval studies (Phase 4)UnknownNCT04739215
What this trial is testing

Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF

Who this might be right for
Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction
Hospital General Universitario Gregorio Marañon 62
Testing effectiveness (Phase 2)Study completedNCT02966834
What this trial is testing

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

Who this might be right for
Cholestasis
GlaxoSmithKline 147
Large-scale testing (Phase 3)Looking for participantsNCT05715814
What this trial is testing

MeChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Who this might be right for
Peritoneal Dialysis ComplicationEnd Stage Kidney DiseaseSodium-glucose Co-transporter-2 Inhibitors+2 more
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT04886258
What this trial is testing

Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Who this might be right for
Symptomatic Knee Osteoarthritis
Novartis Pharmaceuticals 115
Testing effectiveness (Phase 2)Study completedNCT03304678
What this trial is testing

Discovery of Sirolimus Sensitive Biomarkers in Blood

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 33
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Early research (Phase 1)Looking for participantsNCT05950464
What this trial is testing

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04340258
What this trial is testing

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Who this might be right for
HNSCC
University of Cincinnati 50
Not applicableUnknownNCT06116058
What this trial is testing

Integrated Neuromuscular Inhibition Versus Instrument Assisted Soft Tissue Mobilization in Chronic Back Pain

Who this might be right for
Chronic Non Specific Low Back Pain
Cairo University 45
Large-scale testing (Phase 3)Study completedNCT06238024
What this trial is testing

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Who this might be right for
Interleukin-6Ischemic StrokeEndovascular Treatment
Suzhou Municipal Hospital of Anhui Province 108
Post-approval studies (Phase 4)Ended earlyNCT02463110
What this trial is testing

Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin

Who this might be right for
DepressionCoronary Artery Disease
Assistance Publique - Hôpitaux de Paris 2
Large-scale testing (Phase 3)Study completedNCT01763918
What this trial is testing

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Who this might be right for
Hyperlipidemia
Amgen 331
Early research (Phase 1)Ended earlyNCT00780325
What this trial is testing

Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition

Who this might be right for
Healthy Volunteers
University of Pennsylvania 26
Large-scale testing (Phase 3)Study completedNCT01566474
What this trial is testing

Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

Who this might be right for
Barrett's Esophagus
Aragon Institute of Health Sciences 80
Early research (Phase 1)Study completedNCT01960374
What this trial is testing

Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK

Who this might be right for
Healthy Volunteers Pharmacokinetic Study
AstraZeneca 117
Post-approval studies (Phase 4)WithdrawnNCT06536309
What this trial is testing

Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection FractionMyocardial Fibrosis
Brigham and Women's Hospital
Post-approval studies (Phase 4)Study completedNCT03361098
What this trial is testing

DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2

Who this might be right for
Type 2 Diabetes MellitusObesity
Amsterdam UMC, location VUmc 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04920708
What this trial is testing

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

Who this might be right for
Metastatic Breast CancerER+ Breast CancerAdvanced Breast Cancer
Royal Marsden NHS Foundation Trust 57
Not applicableStudy completedNCT04001868
What this trial is testing

Sub Occipital Inhibition Technique on Postural Balance

Who this might be right for
Movement Disorders
Cardenal Herrera University 46
Very early researchLooking for participantsNCT04005690
What this trial is testing

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more
OHSU Knight Cancer Institute 90
Next Page